Performance analysis of SELLAS Life Sciences Group (SLS)
Annual Return
Over the past 3 years, SLS has had an average annual return of +97.69%, outperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, SLS has had an average annual return of +7.46%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Dec 29, 2017, SLS has had an average annual return of -32.83%, underperforming the benchmark SPY, which returned +14.53% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +241.24% | +259.26% | -0% | -55.74% | -57.04% | -4.70% | +35.45% | -93.02% | -84.23% | +0% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0% | +29.90% | -14.29% | +17.59% | +88.19% | +58.16% | -12.43% | +241.24% | |||||
| 2025 | +55.56% | -28.57% | -6.67% | +42.86% | +10% | +27.27% | -26.79% | +19.51% | -16.33% | +14.63% | -10.64% | +130.95% | +259.26% |
| 2024 | -40.74% | +62.50% | -0% | +23.08% | +12.50% | -13.89% | -3.23% | +10% | -3.03% | -6.25% | -3.33% | -6.90% | -0% |
| 2023 | +39.34% | -49.41% | -13.95% | -2.70% | +22.22% | -9.09% | +5% | -9.52% | +10.53% | -40.48% | +8% | +0% | -55.74% |
| 2022 | -3.52% | +13.87% | +9.62% | -59.06% | +11.43% | -26.92% | +15.79% | +18.18% | -33.33% | +130.77% | -49.17% | +0% | -57.04% |
| 2021 | +4.70% | +33.33% | +5.29% | -7.76% | +51.98% | -7.17% | -23.16% | +8.68% | -1.26% | -5.11% | -22.42% | -17.92% | -4.70% |
| 2020 | -34.55% | -26.39% | -16.98% | +47.73% | +35.38% | -14.77% | +21.33% | -39.56% | +23.64% | -2.94% | +45.45% | +55.21% | +35.45% |
| 2019 | +18.71% | -4.81% | -26.60% | -1.99% | -50.00% | -78.00% | +54.61% | -17.89% | -13.41% | +4.52% | -27.16% | -6.78% | -93.02% |
| 2018 | -16.67% | -24.61% | -29.59% | +63.49% | -8.16% | -33.97% | -66.39% | -6.04% | +12.92% | -0% | +46.74% | -31.29% | -84.23% |
| 2017 | +0% | +0% |
Drawdown analysis of SELLAS Life Sciences Group (SLS)
The maximum drawdown for the SLS was -99.89%, occurring on Jan 16, 2024. This drawdown has not yet recovered.
The current SLS drawdown is -97.12%.
Since Dec 29, 2017 SLS has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.89% | Apr 3, 2018 | 1456 | Jan 16, 2024 | Ongoing | Ongoing | Ongoing |
| -55.77% | Dec 29, 2017 | 61 | Mar 29, 2018 | 1 | Apr 2, 2018 | 62 |